GlassScriptPhysician profile
Angela D Saxon
NPI 1710437702
$3,008.47
in general payments reported to CMS, 2019-2025
33 companies · $715 in 2025
The $715 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.11 · 2022: $839 · 2023: $835 · 2024: $593 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,141.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $641.28 | 2022-2025 | |
| Novo Nordisk INC | $292.99 | 2022-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $233.40 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbott Laboratories | $210.40 | 2022-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $202.89 | 2022-2025 | Keveyis, Gvoke Hypopen |
| Lilly USA, LLC | $180.55 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $105.11 | 2022-2023 | Xarelto |
| Pfizer INC. | $99.50 | 2022-2024 | |
| Amgen INC. | $99.35 | 2022-2025 | Otezla, Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $82.79 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $78.39 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.63 | 2022-2025 | |
| Stryker Corporation | $70.35 | 2025 | Clottriever Bold Catheter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.56 | 2023-2024 | Xifaxan, Trulance |
| Phathom Pharmaceuticals, INC. | $67.16 | 2024-2025 | Voquezna |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $44.85 | 2022-2023 | Austedo |
| Paratek Pharmaceuticals, INC. | $44.61 | 2025 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.48 | 2022-2023 | Jardiance |
| Idorsia Pharmaceuticals US INC | $38.87 | 2022-2023 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $34.45 | 2022-2025 | Zoryve |
| Intuitive Surgical, INC. | $33.46 | 2025 | |
| Axsome Therapeutics, INC. | $30.67 | 2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $28.03 | 2022 | |
| Cvrx, INC. | $26.25 | 2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $25.98 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $25.31 | 2024 | Gemtesa |
| Glaxosmithkline, LLC. | $24.10 | 2025 | Arexvy, Shingrix |
| Dexcom, INC. | $24.05 | 2025 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $17.89 | 2023 | Nocdurna, Xyosted, Tlando |
| Corcept Therapeutics | $17.70 | 2023 | Korlym |
| Daiichi Sankyo INC. | $17.53 | 2025 | Injectafer |
| Astellas Pharma US INC | $17.04 | 2024 | Veozah |
| Shield Therapeutics INC | $14.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Saxon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.